Sintilimab as adjuvant therapy for patients with resected HCC at high risk of recurrence

被引：0
|
作者：
Hindson, Jordan
机构：
[1] Nature Reviews Gastroenterology & Hepatology,
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2024年 / 21卷 / 03期
关键词：
D O I：
10.1038/s41575-024-00904-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [31] Adherence to adjuvant therapy in patients (pts) with resected melanoma
    Beisel, C.
    Poretta, T.
    Burke, M.
    Sipsma, H.
    Fuqua, E.
    Stwalley, B.
    Yang, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : B13 - B13
  • [32] Completion of adjuvant therapy in patients with resected pancreatic cancer
    DePeralta, Danielle K.
    Ogami, Takuya
    Zhou, Jun-Min
    Schell, Michael J.
    Powers, Benjamin D.
    Hodul, Pamela J.
    Malafa, Mokenge P.
    Fleming, Jason B.
    HPB, 2020, 22 (02) : 241 - 248
  • [33] ADJUVANT BEVACIZUMAB IS SAFE TREATMENT FOR MELANOMA PATIENTS AT HIGH RISK OF RECURRENCE
    Biswas, S.
    East, C.
    A'Hern, A.
    Marshall, A.
    Dunn, J.
    Lorigan, P.
    Middleton, M.
    Corrie, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 245 - 245
  • [34] Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
    Bin Qiu
    Wei Guo
    Fan Zhang
    Fang Lv
    Ying Ji
    Yue Peng
    Xiaoxi Chen
    Hua Bao
    Yang Xu
    Yang Shao
    Fengwei Tan
    Qi Xue
    Shugeng Gao
    Jie He
    Nature Communications, 12
  • [35] Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
    Qiu, Bin
    Guo, Wei
    Zhang, Fan
    Lv, Fang
    Ji, Ying
    Peng, Yue
    Chen, Xiaoxi
    Bao, Hua
    Xu, Yang
    Shao, Yang
    Tan, Fengwei
    Xue, Qi
    Gao, Shugeng
    He, Jie
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [36] Recurrence-free survival results from a pilot study of adjuvant gefitinib in resected hepatocellular carcinoma (HCC)
    Chopra, Akhil
    Lopes, Gilberto
    Bharwani, Lavina D.
    Chan, Chung Yip
    Chung, Alexander
    Cheow, Peng Chung
    Ho, Choon Kiat
    Liau, Kui Hin
    Woon, Winston
    Low, Jee Keem
    Chang, Alex Yuang-Chi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [37] Salvage Chemoradiation therapy for Loco-regional Recurrence After Adjuvant Gemcitabine in Patients With Resected Pancreatic Adenocarcinoma
    Gemici, C.
    Yaprak, G.
    Tepetam, H.
    Mayadagli, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S324 - S324
  • [38] Evaluation of recurrence patterns after adjuvant chemoradiation therapy in patients with resected pancreatic adenocarcinoma at Johns Hopkins Hospital
    Gavini, S.
    Hsu, C.
    Swartz, M.
    Laheru, D.
    Pawlik, T.
    Schulick, R.
    Wolfgang, C.
    Winter, J.
    Cameron, J.
    Herman, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S260 - S261
  • [39] DOES ADJUVANT HORMONAL THERAPY IMPROVE FREEDOM OF BIOCHEMICAL RECURRENCE IN PATIENTS WITH HIGH-RISK PROSTATE CANCER?
    Abusaris, H.
    Hofman, R.
    van Vulpen, M.
    Batterman, J.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S319 - S320
  • [40] Adjuvant TACE combined with tislelizumab in patients with resected hepatocellular carcinoma at high risk of recurrence: An open-label, multicenter, phase II trial
    Ma, T.
    Wen, L.
    Zhang, J.
    Zhang, Z.
    Zeng, Y.
    Wang, Y.
    Zheng, J.
    Liang, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1494 - S1494
12345